최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Oncology letters, v.17 no.5, 2019년, pp.4557 - 4565
Hwang, Chungsu (Department of Pathology, Pusan National University Yangsan Hospital, Yangsan, Gyeongsangnam-do 50612, Republic of Korea) , Lee, So Jung (Department of Pathology, Pusan National University Hospital, Seo-Gu, Busan 602-739, Republic of Korea) , Lee, Jung Hee (Department of Pathology, Pusan National University Yangsan Hospital, Yangsan, Gyeongsangnam-do 50612, Republic of Korea) , Kim, Ki Hyung (Department of Obstetrics and Gynecology, Pusan National University Hospital, Seo-Gu, Busan 602-739, Republic of Korea) , Suh, Dong Soo (Department of Obstetrics and Gynecology, Pusan National University Hospital, Seo-Gu, Busan 602-739, Republic of Korea) , Kwon, Byung-Su (Department of Obstetrics and Gynecology, Pusan National University Hospital, Seo-Gu, Busan 602-739, Republic of Korea) , Choi, Kyung Un (Department of Pathology, Pusan National University Hospital, Seo-Gu, Busan 602-739, Republic of Korea)
Studies on tumor-infiltrating lymphocytes (TILs) in epithelial ovarian cancer (EOC) have focused on the clinical significance of inflammatory cells of specific subtypes that are identifiable using immunohistochemistry. However, the subtypes of inflammatory cells that reportedly affect patient surviv...
1 Seigel RL Miller KD Jemal A Cancer statistics, 2018 CA Cancer J Clin 68 7 30 2018 10.3322/caac.21442 29313949
2 Clemente CG Mihm MC Jr Bufalino R Zurrida S Collini P Cascinelli N Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma Cancer 77 1303 1310 1996 10.1002/(SICI)1097-0142(19960401)77:7 3.0.CO;2-5 8608507
3 Mahmoud SM Paish EC Powe DG Macmillan RD Grainge MJ Lee AH Ellis IO Green AR Tumor-infiltrating CD8 + lymphocytes predict clinical outcome in breast cancer J Clin Oncol 29 1949 1955 2011 10.1200/JCO.2010.30.5037 21483002
4 Ropponen KM Eskelinen MJ Lipponen PK Alhava E Kosma VM Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer J Pathol 182 318 324 1997 10.1002/(SICI)1096-9896(199707)182:3 3.0.CO;2-6 9349235
5 Fukunaga A Miyamoto M Cho Y Murakami S Kawarada Y Oshikiri T Kato K Kurokawa T Suzuoki M Nakakubo Y CD8 + tumor-infiltrating lymphocytes together with CD4 + tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma Pancreas 28 e26 e31 2004 10.1097/00006676-200401000-00023 14707745
6 Zhang L Conejo-Garcia JR Katsaros D Gimotty PA Massobrio M Regnani G Makrigiannakis A Gray H Schlienger K Liebman MN Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N Engl J Med 348 203 213 2003 10.1056/NEJMoa020177 12529460
7 Sato E Oison SH Ahn J Bundy B Nishikawa H Qian F Jungbluth AA Frosina D Gnjatic S Ambrosone C Intraepithelial CD8 + tumor-infiltrating lymphocytes and a high CD8 + /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proc Natl Acad Sci USA 102 18538 18543 2005 10.1073/pnas.0509182102 16344461
8 Webb JR Milne K Watson P Deleeuw RJ Nelson BH Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer Clin Cancer Res 20 434 444 2014 10.1158/1078-0432.CCR-13-1877 24190978
9 Loi S Sirtaine N Piette F Salgado R Viale G Van Eenoo F Rouas G Francis P Crown JP Hitre E Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02–98 J Clin Oncol 31 860 867 2013 10.1200/JCO.2011.41.0902 23341518
10 Herrero-Vicent C Guerrero A Gavila J Gozalbo F Hernandez A Sandiego S Algarra MA Calatrava A Guillem-Porta V Ruiz-Simon A Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy Ecancermedicalscience 11 759 2017 10.3332/ecancer.2017.759 28900472
11 Salgado R Denkert C Demaria S Sirtaine N Klauschen F Pruneri G Wienert S Van den Eynden G Baehner FL Penault-Llorca F The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 Ann Oncol 26 259 271 2014 10.1093/annonc/mdu450 25214542
12 Loi S Michiels S Salgado R Sirtaine N Jose V Fumagali D Kellokumpu-Lehtinen PL Bono P Kataja V Desmedt C Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: Results from the FinHER trial Ann Oncol 25 1544 1550 2014 10.1093/annonc/mdu112 24608200
13 Denkert C von Minckwitz G Brase JC Sinn BV Gade S Kronenwett R Pfitzner BM Salat C Loi S Schmitt WD Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative breast cancers J Clin Oncol 33 983 991 2015 10.1200/JCO.2014.58.1967 25534375
14 Adams S Gray RJ Demaria S Goldstein L Perez EA Shulman LN Martino S Wang M Jones VE Saphener TJ Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199 J Clin Oncol 32 2959 2966 2014 10.1200/JCO.2013.55.0491 25071121
15 Mignon S Wilard-Gallo K Van den Eynden G Salgado R Waelput W Decoster L Marien K Vansteenkiste J Teugels E De Greve J The relationship of TILs and PD-L1 expression in NSCLC adenocarcinoma in little to non-smokers with driver mutations and outcome parameters J Thorac Oncol 12 S1331 2017 10.1016/j.jtho.2016.11.1883
16 Kang BW Seo An Yoon S Bae HI Jeon SW Kwon OK Chung HY Yi W Kang H Kim JG Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer Ann Oncol 27 494 501 2016 10.1093/annonc/mdv610 26673353
17 Sudo T Nishida R Kawahara A Saisho K Mimori K Yamada A Mizogchi A Kadoya K Matono S Mori N Clinical impact of tumor-infiltrating lymphocytes in esophageal squamous cell carcinoma Ann Surg Oncol 24 3763 3770 2017 10.1245/s10434-017-5796-4 28160141
18 Ahn SG Jeong J Hong S Jung WH Current issues and clinical evidence in tumor-infiltrating lymphocytes in breast cancer J Pathol Transl Med 49 355 363 2015 10.4132/jptm.2015.07.29 26278518
19 James FR Jiminez-Linan M Alsop J Mack M Song H Brenton JD Pharoah PDP Ali HR Association between tumor infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer BMC Cancer 17 657 2017 10.1186/s12885-017-3585-x 28931370
20 Tomsová M Melichar B Sedlákovál I Steiner I Prognostic significance of CD3 + tumor-infiltrating lymphocytes in ovarian carcinoma Gynecol Oncol 108 415 420 2008 10.1016/j.ygyno.2007.10.016 18037158
21 Hermans C Anz D Engel J Kirhner T Endres S Mayr D Analysis of FoxP3 + T-regulatory cells and CD8 + T-cells in ovarian carcinoma: Location and tumor infiltrating patterns are key prognostic markers PLos One 9 e111757 2014 10.1371/journal.pone.0111757 25365237
22 Slaney CY Kershaw MH Darcy PK Trafficking of T cells into tumor Cancer Res 74 7168 7174 2014 10.1158/0008-5472.CAN-14-2458 25477332
23 Schietinger A Arina A Liu RB Wells S Huang J Engels B Bindokas V Bartkowiak T Lee D Hermann A Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer Oncoimmunology 2 e26677 2013 10.4161/onci.26677 24482750
※ AI-Helper는 부적절한 답변을 할 수 있습니다.